Economy & Markets

Manchin and the reconciliation bill

You have all seen the news articles by now. The short version: Pelosi encouraged House Democrats to pass a bill that Manchin said all along he would not agree to. One article referred to Pelosi “frog-marching House Democrats to the pot”. Perhaps the White House thought that they would be able to change Manchin’s mind; in any case, it didn’t work. Manchin made an offer to the White House recently with his own $1.8 trillion bill, which the White House rejected. Instead, the White House attacked Manchin publicly yesterday with language usually reserved for people in the opposing party, which they might have deemed appropriate since Manchin made his final reservations known while being interviewed on Fox News. The fallout:

  • It is still possible that the reconciliation bill gets resurrected. Progressives in the House and Senate may have to choose between Manchin’s version of the bill or walking away with nothing. Manchin’s version of the bill has not been disclosed but would still presumably include pre-K, a few hundred billion for climate change, Medicaid expansion, housing subsidies, higher education benefits and workforce training, and changes to Medicare drug price caps and price setting. The big exclusions: paid leave, Medicare expansion, fully refundable child tax credits with no work requirement and some other items. 
  • Even for the items that Manchin would include, he appears to want them scored from a budget perspective as if they are permanent rather than temporary. He reportedly considers temporary spending programs that phase out as budget gimmicks given the likelihood that such programs may be made permanent at some point, in which case they would have a larger impact on the budget deficit. Specifically: as passed by the House, the cost of the child tax credit, pre-K, health insurance subsidies and home & community based care would be $770 bn.  But if made permanent, their costs would rise to $3.0 trillion
  • Manchin also mentioned the need for changes in the way that climate spending is allocated, the importance of grid reliability, and mentioned California and Texas as examples of where the renewable transition is happening too fast for local energy markets to adapt to. He might also have been thinking about the situation in Europe right now (see first chart). Falling investment in thermal energy, unreliable supplies of Russian natural gas, a cold winter in Russia and Europe, lower than expected wind speeds, emergency repairs of French nuclear plants and rising CO2 permit prices have resulted in sky-rocketing electricity prices across Europe
  • Manchin also mentioned inflation concerns; headline CPI may rise further in the next few months before falling again, making passage of a large bill more difficult
  • In case no bill is resurrected, Goldman Sachs economists announced today that they would cut their US GDP growth forecasts by around 0.5% for 2022 given the front-loaded nature of the reconciliation bill spending
  • If no bill is passed, renewable energy stocks could be negatively affected, and it could be a moderate positive for biotech and pharma since the reconciliation bill included provisions to cap drug prices and allow Medicare to begin negotiating drug prices in 2025 for 10 older drugs with no generic competition; by 2030 this would rise to 100 drugs. While the corporate tax provisions in the bill would not be implemented, the TJCA would still be in force and would require companies in 2022 to start amortizing R&D and software development costs over 5 years, expenses which are now fully deductible in year 1. Congress may somehow prevent this from happening, but it could take time in a no-bill scenario. One more thing on taxes: if the reconciliation bill is not passed or is seriously altered, it is not clear how other countries would react regarding negotiations to establish a global minimum tax regime and their agreement to temporarily suspend digital service taxes on US tech firms, and the decision by the US to temporarily suspend imposition of tariffs in response.
  • The reconciliation (build back better) bill relied heavily on upfront spending offset by net tax increases and spending cuts in later years to be deemed deficit-neutral. The fourth chart shows the reconciliation bill relative to the size of the infrastructure bill.
  • Some government relations people on Wall Street believe that Manchin is not operating alone and has implicit support from other members. I’m not so sure. While Sinema has made her objections to corporate tax increases known, that’s about it. Senators Hassan, Kelly and Masto also reportedly have some reservations about the House version of the bill, but as far as I can tell have not said much publicly indicating that they would not vote for it as it is written. The bigger picture politically: if Democrats had won 52-54 seats in 2020 as they were projected to, Manchin’s objections could be ignored. And if Republicans had been able to hold onto one or both Senate seats in the Georgia runoff as they were expected to, there would be no reconciliation bill to begin with.
  • Manchin is one of the last remaining conservative Southern Democratic Senators. The Southern Democratic Leadership Council was formed in 1985 in the wake of Mondale’s loss, and rose to prominence during the Clinton era. As shown in the second chart, non-conformists in the Senate in both parties collapsed by the year 2000, and the Southern Democratic Leadership Council was disbanded in 2011 as the party became more progressive. The third chart shows where Manchin and Sinema exist within a spatial polarization chart of the 116th Congress based on congressional voting histories.

Have a good holiday and get your booster shot. The last chart shows the substantial increase in vaccine efficacy from a booster shot against both Delta and Omicron variants. Boosters increase the concentration of neutralizing antibodies and also appear to create antibodies targeting more parts of the virus than the first two shots. Even if the booster shot does not prevent respiratory infection from Omicron, there are preliminary signs that it may prevent more serious pulmonary and neurological damage which puts people in the hospital. See our web portal Section 5 for more on the Omicron variant.

Line chart shows US vs Europe day ahead electricity prices since 2015. Chart shows that electricity prices for France, Spain and Germany spiked from levels below $100 per MWh to $388, $348 and $320 respectively at the end of 2021. US electricity prices have remained fairly steady at around $50 per MWh at its most recent point.
Line chart shows the number of party non-conformists in the Senate (senators who vote against their own party) since 1958. Chart shows that total non-conformists as well as republican and democrat non-conformists have steadily declined since 1958.
Dot plot chart showing 2019-2020 senate polarization scores for the 116th congress, with higher positive scores indicating senators are more liberal and lower negative scores indicating senators are more conservative. The chart highlights Manchin as having a score slightly above 0, indicating the senator is the most moderate of the liberal senators.
Bar chart shows the deficit impact of the Build Back Better and infrastructure bills shown in billions of dollars. Chart shows that in 2022 through 2016 both the Bipartisan Infrastructure Framework and the Build Back Better plan would increase the deficit. From 2027 through 2030 the Build Back Better plan decreases the deficit but the bipartisan infrastructure framework would increase the deficit. In 2031, both bills would decrease the deficit by around $150 billion.
Bar chart shows Pfizer vaccine efficacy against symptomatic infection against Delta and Omicron for fully vaccinated people and those after receiving a booster shot. Chart shows that people fully vaccinated with the Pfizer vaccine have 60% efficacy against symptomatic infection caused by Delta, compare to 95% efficacy for those receiving the booster. Against the omicron variant, fully vaccinated efficacy is around 35% compared to 75% for those after receiving the booster.

Contact us to discuss how we can help you experience the full possibility of your wealth.

Please tell us about yourself, and our team will contact you. 

*Required Fields

Contact us to discuss how we can help you experience the full possibility of your wealth.

Please tell us about yourself, and our team will contact you. 

Enter your First Name

> or < are not allowed

Only 40 characters allowed

Enter your Last Name

> or < are not allowed

Only 40 characters allowed

Select your country of residence

Enter valid street address

> or < are not allowed

Only 150 characters allowed

Enter your city

> or < are not allowed

Only 35 characters allowed

Select your state

> or < are not allowed

Enter your ZIP code

Please enter a valid zipcode

> or < are not allowed

Only 10 characters allowed

Enter your postal code

Please enter a valid zipcode

> or < are not allowed

Only 10 characters allowed

Enter your country code

Enter your country code

> or < are not allowed

Enter your phone number

Phone number must consist of 10 numbers

Please enter a valid phone number

> or < are not allowed

Only 15 characters allowed

Enter your phone number

Please enter a valid phone number

> or < are not allowed

Only 15 characters allowed

Tell Us More About You

0/1000

Only 1000 characters allowed

> or < are not allowed

Checkbox is not selected

Your Recent History

LEARN MORE About Our Firm and Investment Professionals Through FINRA BrokerCheck

 

To learn more about J.P. Morgan’s investment business, including our accounts, products and services, as well as our relationship with you, please review our J.P. Morgan Securities LLC Form CRS and Guide to Investment Services and Brokerage Products

 

JPMorgan Chase Bank, N.A. and its affiliates (collectively "JPMCB") offer investment products, which may include bank-managed accounts and custody, as part of its trust and fiduciary services. Other investment products and services, such as brokerage and advisory accounts, are offered through J.P. Morgan Securities LLC ("JPMS"), a member of FINRA and SIPC. Insurance products are made available through Chase Insurance Agency, Inc. (CIA), a licensed insurance agency, doing business as Chase Insurance Agency Services, Inc. in Florida. JPMCB, JPMS and CIA are affiliated companies under the common control of JPMorgan Chase & Co. Products not available in all states.

 

Please read the Legal Disclaimer for key important J.P. Morgan Private Bank information in conjunction with these pages.

INVESTMENT AND INSURANCE PRODUCTS ARE: • NOT FDIC INSURED • NOT INSURED BY ANY FEDERAL GOVERNMENT AGENCY • NOT A DEPOSIT OR OTHER OBLIGATION OF, OR GUARANTEED BY, JPMORGAN CHASE BANK, N.A. OR ANY OF ITS AFFILIATES • SUBJECT TO INVESTMENT RISKS, INCLUDING POSSIBLE LOSS OF THE PRINCIPAL AMOUNT INVESTED

Bank deposit products, such as checking, savings and bank lending and related services are offered by JPMorgan Chase Bank, N.A. Member FDIC.

Not a commitment to lend. All extensions of credit are subject to credit approval.

Equal Housing Lender Icon